Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL23201208

N=C(NC(=O)O)c1ccc(CN)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
NCOR2 Q9Y618 1/20 0.44
LOXL2 Q9Y4K0 2/20 0.43
F10 P00742 1/20 0.43
ITGB3 P05106 3/20 0.41
ITGB1 P05556 3/20 0.41
ITGAV P06756 3/20 0.41
ITGA5 P08648 3/20 0.41
TMPRSS6 Q8IU80 7/20 0.40
KLK1 P06870 2/20 0.40
KLK5 Q9Y337 2/20 0.40
ITGB5 P18084 2/20 0.39
ITGB2 P05107 1/20 0.39
ITGB6 P18564 1/20 0.39
ITGAL P20701 1/20 0.39
F2 P00734 6/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5395162 0.91 LOXL2 (0.52) HDAC3HDAC6NCOR2LOXL2F10
Hydrochloric Acid SCHEMBL6792710 0.89 LOXL2 (0.50) HDAC3HDAC6NCOR2LOXL2F10
Hydrochloric Acid SCHEMBL6789524 0.89 LOXL2 (0.50) HDAC3HDAC6NCOR2LOXL2F10
Trifluoroacetic Acid SCHEMBL30387154 0.87 LOXL2 (0.50) HDAC3HDAC6NCOR2LOXL2F10
Trifluoroacetic Acid SCHEMBL30385710 0.85 LOXL2 (0.42) HDAC3HDAC6NCOR2LOXL2F10
Trifluoroacetic Acid SCHEMBL30386986 0.83 MASP2 (0.44) HDAC3HDAC6NCOR2LOXL2F10
SCHEMBL31205801 0.81 LOXL2 (0.39) HDAC3HDAC6NCOR2LOXL2F10
Trifluoroacetic Acid SCHEMBL30386559 0.81 MASP2 (0.42) HDAC3HDAC6NCOR2LOXL2F10
Trifluoroacetic Acid SCHEMBL30387125 0.81 MASP2 (0.43) HDAC3HDAC6NCOR2LOXL2F10
Trifluoroacetic Acid SCHEMBL30387690 0.81 F2 (0.45) ITGB3TMPRSS6F2PLGPLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230145071-A1 MASP-2 INHIBITORS AND METHODS OF USE OMEROS CORPORATION 2023-05-11 US disclosed
US-11584714-B2 MASP-2 inhibitors and methods of use OMEROS CORPORATION (US) 2023-02-21 US disclosed
EP-3802489-A2 MASP-2 INHIBITORS AND METHODS OF USE Omeros Corporation (US) 2021-04-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11584714-B2 MASP-2 inhibitors and methods of use MASP2, METAP2, SPINT2 HDAC3 2682/4885HDAC6 1158/4885NCOR2 1303/4885
US-20230145071-A1 MASP-2 INHIBITORS AND METHODS OF USE MASP2, METAP2, SPINT2 HDAC3 2682/4885HDAC6 1158/4885NCOR2 1303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.